'Lame Duck' Congress Has High Stakes For Pharma Companies

 
• By Michael McCaughan

Industry faces an uphill fight in a last-ditch effort to reverse the Medicare “donut hole” changes enacted at the start of 2018. At the same time, a stand-off over OTC monograph reform could have ripple effects on the plans to modernize the US FDA Office of New Drugs.

Ducks follow me, cute ducklings (duck babies) following mother in a queue,lake,symbolic figurative harmonic peaceful animal family portrait following team grouping together group trust safety harmony
Can legislators get their ducks in a row to complete pharma legislation?

More from Regulation

More from Policy & Regulation